Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer. | EMBO Rep | 2024 | 38907027 | PubTator, text mining | PubMed |
| Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC. | Bioorg Chem | 2024 | 38823310 | PubTator, text mining | PubMed |
| Discovery of LLC355 as an Autophagy-Tethering Compound for the Degradation of Discoidin Domain Receptor 1. | J Med Chem | 2024 | 38730324 | PubTator, text mining | PubMed |
| Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. | Pharmaceuticals (Basel) | 2024 | 38675389 | PubTator, text mining | PubMed |
| DDR1-targeted therapies: current limitations and future potential. | Drug Discov Today | 2024 | 38580164 | PubTator, text mining | PubMed |
| Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1. | Oncogene | 2024 | 38570692 | PubTator, text mining | PubMed |
| MolProphet: A One-Stop, General Purpose, and AI-Based Platform for the Early Stages of Drug Discovery. | J Chem Inf Model | 2024 | 38563534 | PubTator, text mining | PubMed |
| Dryland microbiomes reveal community adaptations to desertification and climate change. | ISME J | 2024 | 38552152 | PubTator, text mining | PubMed |
| Associations of altered leukocyte DDR1 promoter methylation and childhood trauma with bipolar disorder and suicidal behavior in euthymic patients. | Mol Psychiatry | 2024 | 38503928 | PubTator, text mining | PubMed |
| Recent Advances in Automated Structure-Based De Novo Drug Design. | J Chem Inf Model | 2024 | 38485516 | PubTator, text mining | PubMed |
| Research progress of DDR1 inhibitors in the treatment of multiple human diseases. | Eur J Med Chem | 2024 | 38452728 | PubTator, text mining | PubMed |
| Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery. | Life (Basel) | 2024 | 38398742 | PubTator, text mining | PubMed |
| Coexpression network analysis of the adult brain sheds light on the pathogenic mechanism of DDR1 in schizophrenia and bipolar disorder. | Transl Psychiatry | 2024 | 38395959 | PubTator, text mining | PubMed |
| Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma. | Exp Hematol Oncol | 2024 | 38388466 | PubTator, text mining | PubMed |
| Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. | Front Pharmacol | 2024 | 38384298 | PubTator, text mining | PubMed |
| Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms. | Mol Psychiatry | 2024 | 38374360 | PubTator, text mining | PubMed |
| Evaluation of t-DARPP Expression Alteration in Association with DDR1 Expression in Non-Small Cell Lung Cancer. | Iran Biomed J | 2024 | 38308500 | PubTator, text mining | PubMed |
| Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. | PLoS One | 2024 | 38295140 | PubTator, text mining | PubMed |
| The mir-199b-5p encapsulated in adipocyte-derived exosomes mediates radioresistance of colorectal cancer cells by targeting JAG1. | Heliyon | 2024 | 38293473 | PubTator, text mining | PubMed |
| Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review. | Front Pharmacol | 2024 | 38292938 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=10